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Dry Eye Prevalence Study GroupRS an
ElsevPURPOSE: To assess the prevalence and severity of dry-eye disease in patients with myopia being
evaluated for laser in situ keratomileusis.
SETTING: Nine ophthalmology centers in Russia.
DESIGN: Prospective noninterventional cross-sectional study.
METHODS: The assessments included the Schirmer I test, tear breakup time (TBUT), lissamine
green and fluorescein staining (Oxford grading scheme), Ocular Surface Disease Index (OSDI)
questionnaire, and Dry Eye Workshop (DEWS) dry-eye severity grading.
RESULTS: The study comprised 400 patients with myopia (mean age 29.7 years); 145 (36.2%)
wore contact lenses, and 81 (20.2%) used topical dry-eye medication. The mean Schirmer test
score was 15.2 mm; 36.5% of patients had evidence of tear-volume deficiency (Schirmer score
%10 mm). The mean TBUT was 11.7 seconds; 10.1% of patients had tear-film instability
(TBUT <5 seconds). Conjunctival (lissamine green) staining intensity was categorized as
minimal or greater (gradeR1) in 62.3% of patients and mild or greater (grade R2) in 22.8% of
patients. The mean OSDI score was 20.4, indicating mild ocular disability. Dry-eye severity
(DEWS grading) was mild/episodic in 66.2%, moderate in 29.5%, and severe in 4.3% of
patients. No clear correlation was evident between the Schirmer/TBUT scores and the lissamine
green/OSDI scores.
CONCLUSIONS: The prevalence of dry eye in this population was estimated at approximately 10% to
40% (based on clinical signs) and 40% to 55% (based on symptoms); dry-eye severity was
predominantly mild/episodic. The proportion of patients requiring dry-eye therapy (based on
OSDI and DEWS severity findings) was almost 2 times higher than the proportion receiving
treatment.
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Supplemental material available at www.jcrsjournal.org.Dry-eye disease (keratoconjunctivitis sicca) is a
chronic condition that is characterized by tear-film
instability, tear hyperosmolarity, ocular surface
inflammation, and damage resulting from reduced
tear quality and/or quantity.1 Symptoms typically
include ocular irritation, discomfort, sensitivity to
light, redness, fatigue, and transient blurring of vision.
Although a considerable volume of epidemiologic
research on dry eye has been published in the pastd ESCRS
ier Inc.2 decades,2–9 the prevalence of the disease is difficult
to establish with certainty given the diagnostic diffi-
culties caused by the weak correlation between objec-
tive clinical measures and the symptoms of dry eye.10
Large population-based epidemiologic studies in the
United States, Australia, Taiwan, Indonesia, and
China indicate that the prevalence of dry-eye symp-
toms ranges from approximately 5% to 50% depend-
ing on age group, ethnicity, and diagnostic criteria.2–9http://dx.doi.org/10.1016/j.jcrs.2015.11.038 427
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428 DRY EYE IN LASIK CANDIDATESDry eye is 1 of the most frequent complications of
laser in situ keratomileusis (LASIK), affecting up to
60% of patients during the early postoperative
period.11–16 Development of post-LASIK dry eye is
believed to be caused by surgical transection and laser
ablation of corneal sensory nerve fibers, resulting in
decreased corneal sensitivity and interruption of the
corneal–neural–lacrimal reflex arc that controls tear
production and clearance and the blink rate.17,18 Alter-
ations in corneal shape, resulting in uneven tear-film
distribution, and changes in tear composition caused
by goblet cell damage, are also thought to be contri-
buting factors.17,19 Severe and persistent post-LASIK
ocular symptoms might have a neuropathic compo-
nent and could be indicative of corneal neuralgia
rather than of disrupted tear dynamics.20,21
The limited available data in the literature suggest
that dry-eye signs and symptoms are also common in
candidates for LASIK,22,23 which might be related to
the high proportion of long-term contact lens wearers
in this population.24 Although dry eye is not an abso-
lute contraindication to LASIK, it can adversely affect
the postoperative visual outcome. The presence of pre-
operative dry eye predisposes toward more severe
and/or prolonged dry eye and delayed recovery of
corneal sensitivity after LASIK.22,23,25,26 To optimize
post-LASIK visual outcomes and patient satisfaction,
it is important that patients with dry eye are identified
and treated appropriately before proceeding with
surgery.15
The purpose of this observational study was to
assess the prevalence and severity of dry-eye disease
in patients with myopia seeking ophthalmologic
consultation for LASIK in Russia.Submitted: January 30, 2015.
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J CATARACT REFRACT SURG -PATIENTS AND METHODSStudy DesignPatients 18 years or older attending ophthalmology
clinic consultation for prospective LASIK for myopia
were enrolled in this prospective noninterventional cross-
sectional observational study at 9 ophthalmology centers
inMoscow, St. Petersburg, Ivanovo, NizhnyNovgorod, Eka-
terinburg, Krasnodar, and Stavropol. All patients presenting
for ophthalmologic consultation at the study centers be-
tween May and September 2013 were considered eligible
for study inclusion, regardless of their suitability for LASIK
and their ocular treatment status. No specific study exclusion
criteria were applied. Patients who were receiving ongoing
treatment for dry eye were not instructed to withhold treat-
ment during the study. Each patient's involvement in the
study lasted 1 day, during which a series of dry-eye assess-
ments was performed. The study was performed in
accordance with the tenets of the Declaration of Helsinki
and International Conference on Harmonisation (ICH)
Good Clinical Practice guidelines. The study protocol was
approved by the ethics committee at each study center,
and all patients provided written informed consent before
study participation.Outcome MeasuresSchirmer I Test A standard Schirmer strip was placed over
the lower eyelidmargin, and the length of paper wettingwas
determined after 5 minutes. The test was performed without
the use of local anesthesia andwith the eye closed. A Schirm-
er cutoff value of less than 10mm/5minwas used to indicate
reduced tear volume.27
Tear Breakup Time Test Sodium fluorescein 2.0% solution
was instilled into the inferior fornix using a moistened paper
strip. The fluorescein-stained tear filmwas examined using a
slitlamp with a blue–green filter, and the time from the last
complete blink until the first appearance of a dry spot in
the tear film (ie, tear breakup time [TBUT]) was recorded.
A TBUT of less than 5 seconds was taken to signify a high
likelihood of tear-film instability; TBUT values of 5 to 10 sec-
onds were considered to be of borderline significance.27
Lissamine Green and Fluorescein Staining (Oxford Grading
Scheme) Lissamine green and fluorescein dyes were
instilled into the inferior fornix using an impregnated paper
strip, and the test eye was examined under a slitlamp. Stain-
ing intensity on the exposed ocular surface (cornea and inter-
palpebral conjunctiva) was assessed against standard charts
and graded on a 6-point scale ranging from 0 (lowest inten-
sity) to 5 (highest intensity) according to the Oxford grading
scheme.28 Fluorescein staining findings were not reported by
the investigators and were used only in the assessment of
Dry Eye Workshop (DEWS) dry-eye severity.
Ocular Surface Disease Index Questionnaire Patients
answered 12 questions on the Ocular Surface Disease Index
(OSDI) questionnaire.29 The questions asked about the fre-
quency of ocular symptoms during the past week (3 items),
visual problems affecting daily activities (6 items), and
ocular discomfort triggered by environmental factors (3
items). Each item was graded from 0 (none of the time) to
4 (all of the time). The OSDI total score (12 items), a measure
of ocular disability related to dry eye, was expressed on a
scale ranging from 0 (no disability) to 100 (completeVOL 42, MARCH 2016
429DRY EYE IN LASIK CANDIDATESdisability). The level of ocular disability was categorized on a
4-tier scale ranging from none (OSDI total score%12) to se-
vere (OSDI total scoreR33).30
Dry Eye Workshop Dry-Eye Severity Grading Based on the
physician's overall assessment of symptoms of ocular
discomfort and visual disturbance; clinical signs in the eyelid
margins, tear film, cornea, and conjunctiva; as well as
Schirmer and TBUT test results, dry-eye severity was catego-
rized on a 4-tier scale ranging from level 1 (mild and/or
episodic) to level 4 (severe and/or disabling and constant).
The diagnostic tests were performed in a fixed sequence
(lissamine green staining, TBUT, fluorescein staining, and
Schirmer), with an interval of 2 to 10 minutes between
each test. Schirmer and TBUT tests were performed in both
eyes, and the results were presented for the patient's worse
eye in each case. Information on the patient's home and
workplace environment, medical history, concomitant
ophthalmologic conditions, current ocular medication,
and contact lens use was also recorded by the examining
ophthalmologist.Statistical AnalysisThe patients' demographic and clinical characteristics,
stratified according to sex, were summarized using
descriptive statistics. Deviations in Schirmer, TBUT, and
OSDI test scores from normal distribution were assessed
using a general normality test. The null hypothesis that
the test data were normally distributed was rejected if
the P value was 0.05 or less. Distributions of Schirmer,
TBUT, and OSDI test scores, as well as conjunctival (liss-
amine green) staining and DEWS severity gradings, were
compared according to dry-eye medication use (yes versus
no) and contact lens use (current versus previous versus
never), with a P value of 0.05 or less denoting a statistically
significant difference.
RESULTSClinical CharacteristicsThis study evaluated 400 patients (263 women and
137 men). Table 1 shows the patients' demographic
and clinical characteristics. Among the study popula-
tion, 145 patients (36.2%) wore contact lenses (mean
duration of use 7.1 years; median 6.0 years), 111
patients (27.8%) reported health-related problems
arising from computer use, and 42 patients (10.5%)
had a family history of dry-eye disease. The patients'
medical histories indicated a low frequency of medical
risk factors for dry eye, such as Sj€ogren syndrome
(0.2%), hepatitis C infection (0.2%), b-blocker use
(2.5%), and antihistamine use (1.5%). Overall, 163 pa-
tients (40.8%) had a previous and/or current history
of ophthalmologic conditions or procedures in addi-
tion to myopia, of which the most frequent were
astigmatism, peripheral retinopathy, peripheral cho-
rioretinal dystrophy, and scleroplasty (Table 1).
Figure 1 shows the type of dry-eye medications used
in the study population.J CATARACT REFRACT SURG -Dry-Eye SymptomsThe responses to the OSDIOcular Symptomdomain
items (n Z 393 complete responders) indicated that
218 patients (55.5%) experienced sensitivity to light,
197 patients (50.1%) experienced eye grittiness, and
160 patients (40.7%) had sore/painful eyes during
the preceding week. Sensitivity to light, eye grittiness,
and sore/painful eyes were more likely to occur in
women than in men (odds ratio [OR], 1.43 and 95%
confidence interval [CI], 0.99-2.37; OR, 1.55 and 95%
CI, 1.02-2.36; and OR, 1.53 and 95% CI, 0.99-2.37,
respectively) and less likely to occur in users of dry-
eye medication than in nonusers (OR, 0.65 and 95%
CI, 0.38-1.08; OR, 0.47 and 95% CI, 0.28-0.77; OR,
0.66 and 95% CI, 0.40-1.09, respectively). Current con-
tact lens wearers were more likely than current non-
wearers to experience eye grittiness (OR, 0.70 and
95% CI, 0.46-1.05) and sore/painful eyes (OR, 0.84
and 95% CI, 0.55-1.27).Diagnostic Test ResultsTable 2 shows themean andmedian Schirmer scores
for the study population. The distribution of individ-
ual Schirmer scores showed significant departure
from normality (P ! .001), with 144 patients (36.5%
of the tested population) having a score of 10 mm
or less, indicating tear-volume deficiency (Figure 2).
The intergroup comparison showed a statistically sig-
nificant difference in Schirmer score distribution be-
tween contact lens users and nonusers (P Z .035),
with nonusers being more likely to have a score of
10 mm or less. There was no statistically significant
difference in Schirmer score distribution between
current users and nonusers of dry-eye medication
(PZ .565).
The TBUT values deviated significantly from
normal (P ! .001) (Table 2 and Figure 2). The inter-
group comparisons showed a statistically significant
difference in TBUT distribution between current users
and nonusers of dry-eye medication (P Z .008), with
users more likely than nonusers to have a TBUT below
the 5-second cutoff value. No statistically significant
difference in TBUT distribution was noted between
contact lens users and nonusers (PZ .117).
Conjunctival (lissamine green) staining was catego-
rized as minimal (grade 1) or absent (grade 0) in the
majority of patients (Figure 2). The distribution of
staining intensity (lissamine green grading) differed
significantly between current users and nonusers of
dry-eye medication (P ! .001) and between contact
lens wearers and nonwearers (P Z .006). Users of
dry-eye medication and contact lenses were more
likely than their respective counterparts to have
high-grade conjunctival staining.VOL 42, MARCH 2016
Table 1. Demographic and clinical characteristics of the study population.
Characteristic Men (nZ 137) Women (nZ 263) Total (NZ 400)
Age (y)
MeanG SD 29.9G 10.0 29.5G 10.0 29.7G 10.0
Range 18, 62 18, 73 18, 73
Current medical conditions, n (%)
Thyroid disease 2 (1.5) 7 (2.7) 9 (2.2)
Rheumatoid arthritis 1 (0.7) 3 (1.1) 4 (1.0)
Hypertension 2 (1.5) 2 (0.8) 4 (1.0)
Chronic gastritis 1 (0.7) 3 (1.1) 4 (1.0)
Diabetes mellitus 1 (0.7) 2 (0.8) 3 (0.8)
Chronic colpitis 0 2 (0.8) 2 (0.5)
Gastric ulcer 2 (1.5) 0 2 (0.5)
Atopic dermatitis 0 2 (0.8) 2 (0.5)
Dietary allergy 1 (0.7) 1 (0.4) 2 (0.5)
Ophthalmologic history,*n (%)
Astigmatism 5 (3.6) 19 (7.2) 24 (6.0)
Peripheral retinopathy 6 (4.4) 8 (3.0) 14 (3.5)
Peripheral chorioretinal dystrophy 2 (1.5) 9 (3.4) 11 (2.8)
Scleroplasty 0 9 (3.4) 9 (2.2)
Glaucoma 3 (2.2) 4 (1.5) 7 (1.8)
Amblyopia 3 (2.2) 3 (1.1) 6 (1.5)
Blepharitis 2 (1.5) 4 (1.5) 6 (1.5)
Meibomian gland dysfunction 2 (1.5) 4 (1.5) 6 (1.5)
Conjunctivitis 0 5 (1.9) 5 (1.2)
Laser coagulation 0 4 (1.5) 4 (1.0)
Current dry-eye medication use, n (%) 22 (16.1) 59 (22.4) 81 (20.2)
Contact lens use, n (%)
Current 31 (22.6) 114 (43.3) 145 (36.2)
Previous 26 (19.0) 37 (14.1) 63 (15.8)
Never 80 (58.4) 112 (42.6) 192 (48.0)
*Prior and/or ongoing ophthalmologic conditions/procedures in addition to myopia
430 DRY EYE IN LASIK CANDIDATESDry-Eye SeverityTable 2 shows the mean and median OSDI scores.
The OSDI total score indicated an overall mild level
of ocular disability related to dry eye. TheOSDIOcular
Symptom, Vision-Related Function, and Environ-
mental Trigger subscale scores suggested that all 3Figure 1. Current dry-eye medication used by the study population
(nZ 400).
J CATARACT REFRACT SURG -domains were affected equally and that despite their
high prevalence, dry-eye symptoms generally
occurred infrequently and had a minor impact on
vision-related functioning. Individual OSDI total
scores showed a statistically significant deviation
from normal distribution (P ! .001) (Figure 3). The
distribution of individual OSDI total scores differed
significantly between current users and nonusers of
dry-eye medication (PZ .005), with patients receiving
dry-eye medication more likely than their counter-
parts to have severe ocular disability (OSDI total score
R33). No statistically significant difference in OSDI
score distribution was noted between contact lens
wearers and nonwearers (PZ .128).
Figure 4 shows the physicians' assessments of
the DEWS severity grading. Most cases of dry eye
were classified as mild/episodic. The distribution of
DEWS severity gradings differed significantly be-
tween recipients and nonrecipients of dry-eye medica-
tion (PZ .002), with treated patients more likely than
untreated patients to have a severe (level 3 or higher)VOL 42, MARCH 2016
Table 2. Schirmer I, TBUT, and OSDI test results in the study
population.
Diagnostic Test Men Women Total
Schirmer I test score
Number 135 260 395
Mean (mm)G SD 15.8G 8.8 14.8G 8.9 15.2G 8.8
Median (mm) 15.0 14.0 14.0
TBUT
Number 135 260 395
Mean (s)G SD 13.0G 7.6 11.1G 6.6 11.7G 7.0
Median (s) 11.0 10.0 10.0
OSDI ocular symptom
subscale score
Number 137 262 399
MeanG SD 13.2G 13.1 18.6G 17.4 16.7G 16.3
Median 8.3 16.7 16.7
OSDI vision-related
function subscale
score
Number 137 262 399
MeanG SD 21.6G 20.1 27.4G 22.3 25.4G 21.7
Median 16.7 20.8 20.0
OSDI environmental
trigger subscale
score
Number 129 256 385
MeanG SD 10.1G 16.3 18.0G 21.7 15.4G 20.4
Median 0.0 8.3 8.3
OSDI total score
Number 137 262 399
MeanG SD 16.5G 13.4 22.5G 17.0 20.4G 16.1
Median 12.5 18.2 15.0
OSDI Z Ocular Surface Disease Index questionnaire; TBUT Z tear
breakup time
Figure 2. Distribution of dry-eye diagnostic test scores in the study
population (TBUTZ tear breakup time).
431DRY EYE IN LASIK CANDIDATESDEWS dry-eye severity grading. There was no statisti-
cally significant difference in DEWS severity grading
distribution between contact lens wearers and non-
wearers (PZ .053).Figure 3.Distribution of OSDI ocular disability grading in the study
population (nZ 399) (OSDIZ Ocular Surface Disease Index).DISCUSSION
This study assessed the prevalence and severity of dry-
eye disease in a cohort of 400 consecutive myopia pa-
tients presenting over a 3-month period for assessment
for potential LASIK at ophthalmology centers in
southern and western Russia. Dry-eye characteristics
were assessed using patient disposition data, self-
reports of ocular symptoms and vision-related func-
tioning (OSDI questionnaire), and a range of clinical
tests, including measures of tear production (Schirmer
I test), tear-film stability (TBUT), and ocular surface
damage (lissamine green and fluorescein staining).
The collective results allowed staging of dry-eye
severity using the DEWS grading classification.J CATARACT REFRACT SURG -Assessment of ocular surface damage focused on
conjunctival (lissamine green) staining because it is
considered a sensitive marker of early-stage dry
eye,31 in particular in contact lens wearers.32 Addi-
tional consideration of corneal (fluorescein) staining
would have provided a more complete picture of the
ocular surface, and its absence is a shortcoming of
this study.VOL 42, MARCH 2016
Figure 4. Distribution of DEWS dry-eye severity grading in the
study population (nZ 393) (DEWSZ Dry Eye Workshop).
432 DRY EYE IN LASIK CANDIDATESIn this predominantly young, clinic-based popula-
tion, 10% of patients showed evidence of tear-film
instability and 37% showed deficient aqueous tear
production, as indicated by TBUT and Schirmer tests
performed using the specified cutoff values (TBUT
!5 seconds; Schirmer%10 mm/5 min). Conjunctival
(lissamine green) staining indicated that almost two
thirds (62%) of patients had some evidence of ocular
surface damage (ie, grade R1 staining); although in
most cases this was of minimal intensity (grade 1)
and within the Oxford scoring system's limit of
normality for conjunctival staining.33 Overall, 22% of
the study population had mild to marked ocular sur-
face staining (grade 2 to 4), indicating a degree of
ocular surface damage beyond that resulting from
the normal physiological process of epithelial desqua-
mation. Dry-eye symptoms (sensitivity to light, eye
grittiness, and sore/painful eyes) were experienced
by approximately 40% to 55% of patients, although
in most cases the symptoms occurred only intermit-
tently (less than half the time). However, a small mi-
nority (w5%) of patients reported that dry-eye
symptoms were present most of the time. Overall, vi-
sual problems affecting daily activities and episodes
of ocular discomfort triggered by environmental fac-
tors (eg, low humidity, wind, and air conditioning)
were infrequent according to OSDI questionnaire find-
ings. Based on the study physicians' overall assess-
ments of diagnostic test results, eyelid margins, and
presenting symptoms, 66% of the study population
was judged to have mild/episodic dry eye; 30% had
moderate and episodic/chronic dry eye, and 4% had
severe and frequent/constant dry eye in the absence
of environmental triggers.
The Schirmer I test performed without anesthesia
provides an estimate of total (basal plus reflex) tear
production and is the most widely used technique to
diagnose dry eye.34 Cutoff values used in the Schirmer
test to signify tear-volume deficiency vary from less
than 3 mm/5 min to less than 10 mm/5 min, although
in general a value of 5 mm/5min or less is preferred.35
Lowering the cutoff value of the Schirmer test reducesJ CATARACT REFRACT SURG -its sensitivity (ie, detection rate) but increases its spec-
ificity. In the present study, adoption of a cutoff value
of 5 mm/5 min or less instead of 10 mm/5 min or less
would have lowered the estimated prevalence of tear-
volume deficiency in the tested population to 15%. For
the TBUT test, the established cutoff value is less than
10 seconds, although thresholds as low as 5 seconds or
less (as chosen for the present study) are also used.35
Raising the cutoff value from less than 5 seconds to
less than 10 seconds increases the sensitivity of the
TBUT test but reduces its specificity. Adoption of a
TBUT cutoff value of less than 10 seconds would
have increased the estimated prevalence of tear-film
instability in the study population to 54%. Accord-
ingly, based on generally accepted criteria of tear-pro-
duction deficiency and tear-film instability, the
prevalence of dry-eye signs in the pre-LASIK myopia
patient population is estimated to fall within a range
of approximately 10% to 50%.
Consistent with evidence of a poor correlation be-
tween objective signs and reported symptoms of
dry-eye disease,10,36 the prevalence of dry-eye symp-
toms in the pre-LASIK population appeared to be
higher than the prevalence of tear-volume deficiency,
tear-film instability, and ocular surface damage, with
approximately 40% to 55% of patients experiencing
sensitivity to light, eye grittiness, and sore/painful
eyes during the week before the study (OSDI
questionnaire). Comparisons of patients' test score
distributions also showed marked discrepancies. In
the subgroups of patients with normal Schirmer
(O10 mm/5 min) and normal TBUT (O10 seconds)
scores, 34% and 35% of patients, respectively, were
rated as having moderate or severe ocular disability
related to dry eye (OSDI total scoreR23). Conversely,
of patients with subnormal Schirmer (%10 mm/
5 min) and TBUT (%10 seconds) scores, 66% and
67%, respectively, were rated as having no or minimal
ocular surface damage (grade 0 to 1 lissamine green
staining). In addition, in the subgroup of patients
with severe ocular disability (OSDI total score R33),
the majority (74%) showed low-intensity (grade 0 to
1) lissamine green staining. Accordingly, a diagnostic
approach that considers symptoms and clinical test
findings is likely to provide a more accurate clinical
picture than 1 focusing solely on clinical signs or on
symptoms.
An indirect measure of the prevalence of symptom-
atic dry eye is provided by the number of patients
receiving dry-eye therapy. At the time of the study,
20% of patients reported using dry-eye medication
(typically sodium hyaluronate, polyethylene glycol–
propylene glycol, and polyethylene glycol–hypromel-
lose ophthalmic solutions). In comparison, the OSDI
questionnaire findings indicated that 40% to 55% ofVOL 42, MARCH 2016
433DRY EYE IN LASIK CANDIDATESpatients experienced dry-eye symptoms during the
week preceding the study. Current treatment recom-
mendations for dry-eye disease, based on the
consensus opinion of an expert panel of international
specialists, is that disease severitydas determined us-
ing the DEWS severity grading systemdis the most
important factor for treatment decision making.37
The proportion of study patients requiring dry-eye
therapy, based on combined DEWS severity findings
(34% of patients had dry eye of moderate or higher
severity) and OSDI disability findings (38% of patients
hadmoderate or severe ocular disability), was nearly 2
times higher than the proportion who reported using
it. For patients with longstanding dry eye or pro-
longed contact lens use, who on the basis of the present
study account for approximately 10% of patients
seeking LASIK for myopia in Russia, more active
dry-eye treatment than artificial tears alone is war-
ranted. Accordingly, the study highlights both the
extent of dry eye in a pre-LASIK myopia patient pop-
ulation and the need for more effective preoperative
management of this condition.WHAT WAS KNOWN
 Dry eye is 1 of the most frequent postoperative complica-
tions of LASIK.
 The presence of existing dry eye predisposes toward
more severe and prolonged post-LASIK dry eye.WHAT THIS PAPER ADDS
 Candidates for LASIK surgery for myopia in Russia showed
a high prevalence (w40% to 55%) of dry-eye symptoms;
however, only 20% of patients reported using dry-eye
medication.
 The prevalence of dry eye in the pre-LASIK myopia popu-
lation in Russia, based on objective clinical signs and pre-
specified cutoff values, was approximately 10% to 40%.
 The severity of dry eye in this population was predomi-
nantly mild, although one third of patients had moderate
or severe disease.
DRY EYE PREVALENCE STUDY GROUP
A full list of the Dry Eye Prevalence Study Group is available as
Appendix 1 (available at http://jcrsjournal.org).
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